Limited activity: This researcher has not published recently (last publication: 2008). Profile data may be outdated.
Match tier Listed
Presence Current · Arkansas
Last published 2008
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Jennifer Gurley

Researcher

Unknown Researcher

4 h-index 5 pubs 521 cited

  • Humans
  • Multiple Myeloma
  • Antineoplastic Combined Chemotherapy Protocols
  • Combined Modality Therapy
  • Female
  • Male
  • Middle Aged
  • Drug Administration Schedule
  • Aged
  • Melphalan
  • Treatment Outcome
  • Prognosis
  • Recurrence
  • Hematopoietic Stem Cell Transplantation
  • Chromosome Aberrations

Biography and Research Information

OverviewAI-generated summary

Jennifer Gurley's research has focused on the health and medical impacts of various factors. Her work includes studies on health disparities and outcomes, particularly concerning child and adolescent health. Gurley has also investigated behavioral and psychological aspects related to health, as well as public health research. Her publications primarily date from before 2008, indicating a period of past research activity.

Metrics

  • h-index: 4
  • Publications: 5
  • Citations: 521

Selected Publications

  • Suppression of abnormal karyotype predicts superior survival in multiple myeloma (2008)
    Leukemia 16 citations DOI OpenAlex
  • Completion of premaintenance phases in total therapies 2 and 3 improves clinical outcomes in multiple myeloma (2008)
    Cancer 13 citations DOI OpenAlex
  • Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3 (2007)
    British Journal of Haematology 328 citations DOI OpenAlex
  • Long‐term outcome results of the first tandem autotransplant trial for multiple myeloma (2006)
    British Journal of Haematology 163 citations DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics